-
Clinical Eye Testing Simulation Software Developed
Physicists at University of Tennessee Space Institute in Tullahoma developed a computer model to simulate human eye behavior for testing potential eye treatments. The system written by space institute physics faculty member Ying-Ling Chen (pictured left) aims to improve the efficiency and reduce the time needed by clinical trials involving human eyes. Clinical trials of…
-
University to Develop, Commercialize HIV/AIDS Nanomedicines
Researchers at University of Liverpool in the U.K. are developing nanoscale therapies to treat HIV and AIDS, and collaborating with a company to take the drugs to market. The project is funded by a £1.65 million ($US 2.61 million) grant from the U.K.’s Engineering and Physical Sciences Research Council. The aim of the project is…
-
Janssen Licenses Biotech’s Antibody for Multiple Myeloma
Janssen Pharmaceutical Companies, a division of Johnson & Johnson in Horsham, Pennsylvania, agreed to license a cancer drug targeting multiple myeloma made by biotechnology company Genmab A/S in Copenhagen, Denmark. The agreement has a total potential value of $1.1 billion from upfront, milestone, and royalty payments, as well as an equity investment in Genmab. The…
-
Nanotech Solution Could Block Laser Beams from Aircraft
Researchers at University of Central Florida in Orlando and Carnegie Mellon University in Pittsburgh created a new material based on nanotechnology that could keep lasers from affecting aircraft pilots and sensitive equipment. Optical science professor Jayan Thomas of Central Florida’s NanoScience Technology Center (pictured right) led the team, which published its findings last month in…
-
EU Grant Funds Research on Programmable Chemical Systems
The European Union’s Seventh Framework Programme is funding a project to build autonomous self-assembling electronic microreagents that can exchange chemical and electronic information. Biochemistry professor John McCaskill at Ruhr University Bochum in Germany (pictured left) with colleagues at Bochum and teams from Europe, Israel, and New Zealand, will take part in the three-year, €3.4 million…
-
New Process Simplifies Protein Production for Drug Companies
A chemical engineer at University of Arkansas in Fayetteville developed a new method for producing high quality proteins used in drugs for treating an assortment of disorders. Doctoral candidate Ellen Brune (pictured right) also founded a company, Boston Mountain Biotech, to commercialize the technology. Current industry methods for protein manufacturing require separating out the background…
-
Health Care Technology Accelerator Boosts Seed Funding
Rock Health, an organization that provides seed funding, training, and mentoring for start-up companies in health care technology, says its next class of companies will each receive a $100,000 investment. The funds for these start-ups are being provided by the Mayo clinic and three venture capital firms: Aberdare Ventures, Kleiner Perkins Caufield and Byers, and…
-
Leukemia Genetic Signature, Drug Candidates Identified
Researchers at University of Rochester in New York identified a set of genes behind the early growth of leukemia stem cells, and used those cells to highlight potential existing drugs with the chemistry to target those cells. The team led by senior investigator and Rochester medical school professor Craig Jordan — with colleagues from Weill…
-
Biopharm, Monsanto to Partner on Agricultural Biotechnology
Alnylam Pharmaceuticals Inc. in Cambridge, Massachusetts and Monsanto Company in St. Louis, will collaborate on developing biotechnology applications in agriculture. The agreement has an immediate value to Alnylam of $29.2 million. The 10-year agreement gives Monsanto exclusive rights worldwide to use Alnylam’s platform technology and intellectual property in the field of agriculture. Alnylam is a…
-
National Lab, Software Company Form Text Analysis Subsidiary
Oak Ridge National Lab in Tennessee formed a subsidiary with Professional Project Services (Pro2Serve), an engineering company in Oak Ridge, to provide text analysis services using software developed at the lab. The software, known as Piranha, performs high-volume document analysis for military and security users. Financial terms of the deal were not disclosed. Piranha analyzes…